The director of the Neurology Residency Program at Weill Cornell Medicine provided insight on the experience residents have had during the COVID-19 pandemic and how it has shaped them for the future.
Insights on diagnosis and diagnostic work-up for Duchenne muscular dystrophy.
The associate professor of neurology at Vanderbilt University Medical Center spoke to the findings of a recent study in Huntington disease that assessed the feasibility of selectively knocking down mutant protein expression.
A review of the phase 2 SPRINT study using selumetinib for the treatment of neurofibromatosis type 1 with plexiform neurofibromas.
A discussion on a small trial using adrenocorticotropic hormones (ACTH) to treat acute optic neuritis and improve vision.
The neurologist at Mayo Clinic in Phoenix, Arizona, detailed the importance of further studies of FDA approved medications in different patient populations.
The associate professor of neurology at Vanderbilt University Medical Center offered his perspective on his and colleagues’ study of single nucleotide polymorphisms in Huntington disease.
Considerations for recent data with adjunctive brivaracetam in pediatric patients with primary generalized seizures or mixed seizure types.
The rationale behind an ongoing study assessing the response rate, safety, and tolerability of repository corticotropin injection in patients with relapsing-remitting multiple sclerosis who have an inadequate response to high-dose steroids.
SAP Partner Banner